Reactivation

Related by string. reactivations . reactivation * * develop HBV reactivation . CMV reactivation . recompletions reactivations development . hepatitis B reactivation . Hepatitis B reactivation . Reactivation Transaction . viral reactivation *

Related by context. All words. (Click for frequent words.) 56 reactivation 51 Signaling Pathway 50 Confirmatory 50 Medicure Announces 50 Main Outcome Measure 50 JCV 50 Radiation Induced 49 Deactivation 49 Antitumor 49 Private Placement Closed 49 Exclusivity Period 49 Reclamation Permit 49 Epstein Barr Virus EBV 49 Miraculins Announces 48 Bulk Sampling Program 48 Reverse Takeover 48 Genetic Mutation 48 Inactivation 48 Bought Deal Financing 48 Oncogenic 48 Terminate Merger 48 Temporary Closure 48 Polymorphisms 47 Macrophage 47 Tumor Suppressor Gene 47 Preventive Measures 47 Crowflight Announces 47 Catheter Associated 47 NDA Submission 47 Reactivate 47 -Rejustors 47 Drug Prevents 47 Conditional Approval 47 Regular Monthly Distributions 47 Previously Announced Private Placement 47 Installment Payment 47 Proposed Private Placement 47 Value Creation Plan 47 Preterm Delivery 47 Reduce Expenses 46 Test Detects 46 Uterine Cancer 46 Transplant Recipient 46 Reevaluation 46 Shareholder Approval 46 Dilatation 46 Conditions Precedent 46 Treating Chronic 46 Becomes Effective 46 Rocmec Closes 46 Positive Feasibility Study 46 ViRexx Announces 46 Relinquishment 46 Breast Cancer Stem Cells 46 Endometrial 46 Contralateral 46 Private Placement Offering 46 Skeletal Muscle 46 Fundoplication 46 Susceptibility Testing 46 Proposed Qualifying Transaction 46 Abolishment 46 Rectification 46 Smooth Muscle 46 Stockholder Approval 46 Share Issuance 46 Inhibit 45 Error Message 45 Merger Transaction 45 autosomal recessive disorder 45 Mitigated 45 Clinical Trial Data 45 Results Confirm 45 Debenture Financing 45 Drilling Permit 45 Greystar Resources Announces 45 Flagstone Re Announces 45 Shareholder Meeting Date 45 Prolongation 45 Big Daddy Chromite 45 Proposed Reorganization 45 Resume Trading 45 Newmont Declares Regular 45 Shareholders Approve Proposed 45 Asset Swap 45 Provides Clarification 45 Reprogrammed 45 Receives Conditional Approval 45 Genetic Defect 45 NMDA Receptor 45 Gene Variation 45 & Workover Fluids 45 Recalculation 45 Mining License 45 Partial Redemption 45 Appears Safe 45 Genes Linked 45 Clinical Outcome 45 Airborne geophysical surveys 45 Mechel Announces 45 Cytomegalovirus CMV 45 Airborne Geophysical Survey 45 Helps Detect 44 Percent Reduction 44 Tumor Growth 44 Aneuploidy 44 Debt Repayment 44 Comair Pilots 44 Synaptic Plasticity 44 Inhaled Nitric Oxide 44 Muscle Wasting 44 Formal Agreements 44 Cancer Recurrence 44 Balance Sheet Restructuring 44 Varicella zoster virus 44 Patients Receiving 44 Helps Predict 44 Non Brokered Financing 44 Trenching Results 44 renal cysts 44 Dia Bras Announces 44 Thromboembolic 44 Temporary Shutdown 44 Ground Geophysics 44 Predict Risk 44 NYSE Amex Listing 44 Antibiotic Resistant 44 Endometrial Cancer 44 Bladex Announces 44 Substantial Completion 44 monocytes macrophages 44 Bulk Sampling 44 Acquisition Transaction 44 Antidepressant Treatment 44 Leg Ulcers 44 Lowers Risk 44 ZTEST Announces 44 Prognostic Value 44 Reconstitution 44 Prognostic Factors 44 Proposed Financing 44 Regulatory Approvals 44 Warrants Exercised 44 AvalonBay Communities Announces 44 False Positive 44 Negotiated Settlement 44 Diamyd Medical Diamyd 44 Potentially Fatal 44 Tumor Response 44 Review Mechanism 44 EASA Approval 44 Significantly Improved 44 Land Use Permit 44 EntreMed Presents 44 PDL BioPharma Announces 44 Non Brokered 44 Prenatal Exposure 44 Prioritized 44 Review Initiated 44 NOTCH1 44 Data Suggest 44 Molecular Mechanism 44 Drilling Activity 44 Prenatal Screening 44 Certain Cancers 44 Audited Financials 44 Vaccine Shows Promise 44 Shown Effective 43 Resubmission 43 TowneBank Announces 43 Neuralgia 43 Dividend Distribution 43 FOXP3 + 43 Levels Linked 43 Temoris Resources Inc. 43 interferon γ 43 Quarterly Dividends 43 Acqusition 43 Adverse Effect 43 Medoro Resources Announces 43 Corrective Actions 43 Proposed Amalgamation 43 eIF2 43 Feds Urge 43 Mapimi 43 Efficacy Trial 43 Fatty Liver 43 Therapeutic Intervention 43 Private Placement Financing 43 Rate Adjustment 43 Exploration Drilling 43 Strategic Alternatives Review 43 Renal Function 43 Diagnostic Testing 43 Increases Private Placement 43 Airborne Geophysical 43 Drill Hole Results 43 Creditor Protection 43 downregulation 43 Annual Repurchase Offer 43 Therapy Reduces 43 Drug Regimen 43 Permit Approval 43 Axillary 43 Due Diligence Process 43 Recapitalization Transaction 43 Inflammatory Response 43 Constitutive 43 Erythropoietic 43 Pacific Rubiales Announces 43 CapLease Announces 43 Causing Bacteria 43 Deletion 43 Minimization 43 Mosquito Borne 43 Strengthens Balance Sheet 43 Commencement Date 43 inducible nitric oxide synthase 43 Commences Subsequent 43 Gene Linked 43 Left Ventricular 43 Adjuvant Chemotherapy 43 Announce Shareholder Approval 43 Hazmat Spill 43 Lifts FY# Guidance 43 Airborne Magnetic 43 Early Termination 43 degranulation 43 Breast Density 43 Statin Drugs 43 Reduces Risk 43 Recommence 43 MANAGEMENT DISCUSSION AND ANALYSIS 43 Improves Outcomes 43 Adjuvant Therapy 43 Phase III PREGNANT PROCHIEVE 43 Disabling 43 Left Atrial 43 Demonstrates Efficacy 43 Bloodstream Infections 43 Shows Promise Against 43 Receives Conditional 43 Commence Immediately 43 Voluntary Severance 43 Announce Commencement 43 Readmission 43 Treatment Reduces 43 Listing Approval 43 Antibiotic Treatment 43 Study Shows Benefits 43 Recapitalization Plan 43 Main Outcome Measures 43 Staffing Levels 43 Eradicates 43 Heterogeneity 43 Chemotherapy Improves 43 Viral Load 43 Lorus Therapeutics Announces 43 Hormone Receptor Positive 43 Horizontal Drilling 43 Prevent Child 43 Private Placement Oversubscribed 43 Intra Arterial 43 Solid Tumor 43 Protein Linked 43 IND Filing 43 Mitigates 43 Helps Eliminate 42 Hydrotreater 42 Previously Announced Tender Offer 42 alpha#beta# integrin 42 Hormone Levels 42 Diagnostic Criteria 42 Metallurgical Testwork 42 MLL2 42 KEMET Announces 42 Commence Production 42 Pulmonary Artery 42 Gas Flaring 42 Increased Share Repurchase 42 Provides Operational Update 42 Closes Oversubscribed 42 Minimizes 42 Pinnacle Digest Opinions Requested 42 Blockages 42 Shows Promising 42 Milestone Achieved 42 Breast Tissue 42 Fully Subscribed 42 Lung Infections 42 p#Kip# 42 Uncertainty Surrounds 42 Radiofrequency Ablation 42 Receives Shareholder Approval 42 Vertebral Fracture 42 Mokambo Mine 42 Luna Innovations Announces 42 Tie2 42 Cyclic 42 Timely Manner 42 Has Commenced 42 Successfully Completed 42 Enumeration 42 Potentially Deadly 42 Study Analyzes 42 Oral Fluid 42 Tailings Storage Facility 42 Statistically Significant 42 Cystatin C 42 Delineation 42 Merger Discussions 42 Intractable Hiccups 42 Drilling Completed 42 Oocyte 42 Obtains Extension 42 ROCA Reports 42 Announce Successful Completion 42 Provides Operational 42 Preliminary Findings 42 Zaruma Resources 42 Lesion 42 Warrant Exercise 42 Herpes zoster 42 Bought Deal Offering 42 Counteroffer 42 Impairs 42 Previously Announced 42 Substantially Reduce 42 Imaging Techniques 42 demethylation 42 Improves Survival 42 Dramatically Reduce 42 Enhance Shareholder 42 WebTech Wireless Announces 42 Rate Reduction 42 Strengthen Balance Sheet 42 Excellon Announces 42 Accurate Diagnosis 42 Successful Completion 42 Poniard Pharmaceuticals Announces 42 Underlies 42 histamine dihydrochloride 42 STAT3 signaling 42 Financing Transactions 42 Overallotment Option 42 Its Previously Announced 42 Insulin Sensitivity 42 Nicotine Vaccine 42 Extends Expiry Date 42 Warrant Expiry Date 42 Signs Option Agreement 42 Ischemic 42 Smallpox Vaccination 42 Provides Updates 42 Mandatory Conversion 42 Initiates Drill 42 Debt Financings 42 Increases Non Brokered 42 Puts Strain 42 androgen receptor AR 42 Minimal Impact 42 Reduction 42 tyrosine phosphorylation 42 Predict Prostate Cancer 42 Deferral 42 pDC 42 Analyte 42 Non Negotiable 42 Adverse Event 42 Tumor Cell 42 Depressive Symptoms 42 Lung Tumor 42 Stent Placement 42 Quantifiable 42 PUC Approves 42 Feasibility Report 42 Bile Acid 42 Often Misdiagnosed 42 Emission Reductions 42 Pre Emptive 42 Colorectal Screening 42 Diagnostic Assay 42 Anworth Announces 42 Significant Assay Results 42 Provides Update Regarding 42 Strategic Realignment 42 Cautionary Announcement 42 Regularization 42 Elephantiasis 41 Significantly Reduce 41 cystic fibrosis transmembrane 41 Functional Outcomes 41 proteolytic cleavage 41 Vantex Completes 41 Permitting Process 41 Valve Replacement 41 Microstructure 41 Enters Into Definitive 41 Significantly Increases 41 Electrical Stimulation 41 Amendment BULLETIN DATE 41 Metabolic Disorder 41 Multiplies 41 Preclinical Data 41 Reactivates 41 Termination Benefits 41 Wound Dressings 41 Roaming Charge 41 Vertebral 41 Drug Resistant Tuberculosis 41 Over Allotment 41 Cytogenetic 41 Redomestication 41 Effectively Treats 41 Attenuation 41 Optional Redemption 41 Paralyses 41 Completion 41 JAK2 enzyme 41 Hormonal Therapy 41 Announces Brokered Private 41 Lamaque Gold 41 Reacquisition 41 Bought Deal Private Placement 41 Osteoarthritis Pain 41 Discharge Permit 41 Gastar Exploration Announces 41 Extends Maturity Date 41 Enhance Shareholder Value 41 Taparko Bouroum Gold 41 Realignments 41 Escrow Release 41 Signs Binding Agreement 41 AVI BioPharma Announces 41 First Trimester 41 Significantly Improves 41 Temporarily Suspends 41 Circadian Clock 41 Negative Impact 41 Hematological 41 Urine Test 41 Neonatal Mortality 41 intracellular enzymes 41 Voluntary Delisting 41 Antidepressants Linked 41 Cholinesterase Inhibitors 41 Rig Contract 41 XPEL Announces 41 Indirect Costs 41 Metallurgical Testing 41 Non Dilutive Financing 41 isomerase 41 Kirrin Resources Announces 41 Water Rationing 41 Significantly Expand 41 cytopenia 41 constitute discloseable transaction 41 Hand Transplant 41 Annulled 41 Fracture stimulation 41 receptor RANK 41 Capacity Expansion 41 Hepatitis C Virus Infection 41 Reduces Pain 41 Termination Payments 41 Disease Outbreaks 41 Herpesvirus 41 Amount Amount 41 Heap Leach 41 Announces Debt Settlement 41 Peritoneal 41 Initiates Drilling 41 Conoco Borger #.# 41 IRIDEX Announces 41 Combination Clinical Trial 41 Submits Revised 41 Fears Prompt 41 Soil Sampling 41 Cathepsin B 41 chromosome #p# [002] 41 Isambara 41 Substantial Increase 41 Significant Reduction 41 Infill Drilling 41 Debt Conversion 41 Margin Improvement 41 Scoping Study Preliminary 41 Microsatellite 41 clonogenic 41 Otish Uranium 41 autosomal dominant disorder 41 SLEP 41 Offtake 41 Static Kill 41 RNAi Therapeutics 41 Abnormalities 41 Ozone Pollution 41 Peripheral Arterial 41 Dividend Payment 41 Countermeasures Against 41 Workforce Reduction 41 Evaporates 41 Injection Site 41 Hazardous Chemical 41 Hana Mining Announces 41 Laryngeal Cancer 41 Nalunaq 41 Stock Repurchase 41 Operatorship 41 Lease Renewal 41 Expiration Dates 41 Closes Previously Announced 41 Convertible Unsecured Subordinated Debentures 41 Proposed Transactions 41 Fewer Side Effects 41 Stress Testing 41 Minimisation 41 Schizophrenia Treatment 41 MBMI Closes 41 Executes Definitive 41 Study Reinforces 41 Being Studied 41 Neutralization 41 Reallocation 41 Essakane Mine 41 Etame 7H 41 -#:# GMT/# 41 mediated inhibition 41 Radiation Exposure 40 Testosterone Patch 40 Victim Remembered 40 Lupus Drug 40 Common Stock Repurchase 40 Chertoff Defends 40 Restricts Access 40 Genetic Variation 40 OMRON Announces 40 Shortens 40 Pregnancy Linked 40 Multi Lateral 40 phosphorylates 40 Anisotropic 40 Sniffing Dogs 40 Pre Cancerous 40 Techni lab 40 DTV Coupon 40 Dry Powder Inhalers 40 DNA hypermethylation 40 Structural Changes 40 Reprogramming 40 LOMUCIN TM 40 Malbex 40 Enzyme Leach 40 Sp1 40 Over Subscribed 40 Key Milestones 40 Monocyte 40 Prostate Tumors 40 Closes Flow Through 40 Successful Conclusion 40 Compulsory Acquisition 40 Receives Permit 40 Blood Clot Risk 40 Traumatic Spinal Cord Injury 40 Main Refi 40 Transcriptome 40 HER2 HER3 40 PanAndean 40 Pathologic 40 Help Detect 40 varicella zoster virus VZV 40 Principle AIP 40 Boosts Survival 40 Coronary Artery 40 Study Demonstrates 40 Prospective Randomized 40 Insteel Industries Announces 40 Naturally Occurring 40 Immunomedics Announces 40 Tumor Targeting 40 Resubmit 40 2D Seismic 40 latently infected cells 40 Be Avoided 40 HIF 1alpha 40 Generalized 40 Accelerated Stock Repurchase 40 Xcite Energy Limited 40 Approves Share Repurchase 40 Closes Non Brokered 40 Fleet Modernization 40 drilling recompletions 40 mapping geochemical sampling 40 Debt Refinancing 40 Payback Period 40 Occupational Exposure 40 Helps Identify 40 Completes Previously Announced 40 Common Share Offering 40 Coronary Artery Bypass Surgery 40 Alleviation 40 Debt Elimination 40 Demobilization 40 Venous Thrombosis 40 Issues Resolved 40 HBV HCV 40 Could Save Lives 40 Immunohistochemical 40 Bought Deal 40 MagPotash 40 Opinions Requested 40 Extends Share Repurchase 40 Emissions Reductions 40 Sweeping Reforms 40 Desvenlafaxine Succinate 40 Feds Propose 40 Disablement 40 Arranges Private Placement 40 Closes Second Tranche 40 Clearford Announces 40 Induced 40 Resumption 40 Porphyry Project 40 Harsh Interrogation 40 Cupixi 40 kinase signaling 40 NMT Medical Announces 40 Hormone Refractory Prostate Cancer 40 entitled Compositions 40 Announces Conditional Approval 40 Flight Cancellations 40 Statins Reduce 40 Proposed Offering 40 Completes Non Brokered 40 Shituru 40 Copano Energy Announces 40 TITLE SQL Injection 40 Reduced Risk 40 Vaccine Prevents 40 Waiting Periods 40 Classification Tonnes 40 -agriculture Renson Gasela 40 Roughrider Uranium Deposit 40 ACC2 40 Pose Serious 40 Worse Than Thought 40 erythrocyte 40 SBPA substitution 40 p# MAPK 40 Sterilizing 40 Completes Restructuring 40 Flow Through Private Placement 40 Deaths Prompt 40 Optimised Feasibility Study 40 Significant Improvements 40 Financing Commitment 40 Alange 40 Biofuel Production 40 Helps Smokers Quit 40 Minera Guaira 40 Arises 40 Selectmen Approve 40 Gerdau Ameristeel Announces 40 Wound Closure 40 Highly Pathogenic 40 Approval Process 40 Patent Filing 40 Storie Property 40 ERBITUX therapy 40 #beta HSD1 40 securityholder approvals 40 Attenuates 40 autophagic 40 Convertible Notes Offering 40 Radiometric Survey 40 Remains Unchanged 40 Jobless Benefits Extension 40 Increases Stock Buyback 40 Fancamp Announces 40 Shows Efficacy 40 Completion Date 40 GTP hydrolysis 40 Breakup Fee 40 Contract Signings 40 Human Monoclonal Antibody 40 Drilling Update 40 Tasigna prolongs 40 ATW Transaction 40 Confirms Efficacy 40 Genotypes 40 Brokered Financing 40 Set Asides 40 Prostatectomy 40 Flow Through Financing 40 Significant Increase 40 Can Be Avoided 40 Helps Relieve 40 Assesment 40 QHR Announces 40 Mixed Feelings About 40 Findings Suggest 40 Prolongs 40 Final Tranche 40 Risk Stratification 40 Diminishes 40 ATAC Arimidex Tamoxifen Alone 40 microglial activation 40 Problems Persist 40 Stress Induced 40 Verena Minerals Announces 40 Bacterial Contamination 40 Rate Drops 40 Scare Prompts 40 Finalization 40 Bombardier CSeries Aircraft 40 Hammertoe 39 Reverse Circulation 39 Diesel Exhaust 39 Switching Specialization 39 liver enlargement hepatomegaly 39 Susceptibility Gene 39 overactivation 39 Definition Drilling 39 Survival Rate 39 Pressurization 39 lymphatic vessel 39 Vaca Mahuida 39 Sexually Transmitted 39 Underground Sampling 39 La Mina Porphyry 39 Mitsue Pipelines 39 BPZ Energy Announces 39 Trade Liberalization 39 ERK signaling 39 hypothalamic pituitary 39 Causes Concern 39 Randomized Controlled Trials 39 Combat Bird Flu 39 Import Restrictions 39 Arranges Non Brokered 39 Flexpoint Announces 39 Closes Financing 39 Chromosomal 39 Remains Uncertain 39 geological mapping trenching 39 Extends Term 39 Company Skouries Olympias 39 BMAL1 39 Remains Critical 39 Minimized 39 Nuke Weapons 39 Stockholder Voting 39 QT Financing 39 MAP kinase pathway 39 p# mitogen activated 39 Preventions 39 TSX PTQ OTCBB PTQMF 39 Hemodialysis Patients 39 gamma globin gene 39 Positive Scoping Study 39 Document Formats 39 SABESP Announces 39 Polio Vaccination Campaign 39 polycystin 1 39 Photocatalytic 39 Hsp# Inhibitor 39 Stent Thrombosis 39 Wasting Disease 39 Recurrent Glioblastoma 39 Schiavo Autopsy 39 Deemed Success 39 Receives Stockholder Approval 39 Acceptance Testing 39 Protein Structures 39 Ineligibility 39 Financing Condition 39 Improving Efficiency 39 protein acetylation 39 Integra LifeSciences Announces 39 Rationalization 39 Respond Quickly 39 Sick Leave 39 Initialization 39 Completes Second Tranche 39 SulphCo Announces 39 FOR AN OPEN 39 Amerigo Announces 39 Announces Operational Update 39 Related Costs 39 Alleviates 39 Adipose Tissue 39 Wastewater Facilities 39 humoral immunity 39 Preliminary Scoping Study 39 Competency Evaluation 39 Renal Cell Carcinoma 39 Initial Maturity Date 39 Physician Insights 39 Computed Tomographic 39 glucagon receptor 39 Sample Preparation 39 Condition Assessment 39 Arehada 39 Effective Treatments 39 Ballot Count 39 Watchful Waiting 39 Hedgehog signaling 39 Refueling Outage 39 circulating leukocytes 39 Collaborative Approach 39 Impedes 39 Enters Beta 39 Mammalian Cell Culture 39 Second Tranche 39 Inpatient Psychiatric 39 Definitive Option Agreement 39 Salivary 39 Debt Cancellation 39 Pharmacodynamic 39 Heart Ailments 39 Additional Stock Repurchase 39 NS4A 39 Reactivating 39 Ease Pain 39 ERalpha 39 Routine Immunisation 39 GH IGF 39 detailed geologic mapping 39 Various Types 39 Pretreatment 39 Prompt Payment 39 WorldHeart Announces 39 Improve Outcomes 39 Deadline Arrives 39 proto oncogene 39 Significantly Reduces 39 Suppresses 39 Commences Initial 39 Prestea Underground 39 Genetic Markers 39 Retrenched Workers 39 -ActivClient 39 Swipe Fee 39 Prompts Concern 39 Petrojarl Varg FPSO 39 Lymphatic Filariasis 39 Mln Private Placement 39 Pandemic Response 39 Lung Cancer Treatment 39 Conjugates 39 Antibiotic Use 39 Previously Announced Acquisition 39 Inventory Valuation 39 Deepwater Drilling Moratorium 39 Extracellular Matrix 39 Pose Challenges 39 Hearings Scheduled 39 Spud Date 39 Antidumping Duties 39 Kinetex Announces 39 faune Quebec 39 No Observed Adverse 39 Correlation Between 39 Drill Rigs 39 Curtailments 39 NR2 39 Oroco Announces 39 Brain Metastases 39 Prevent Genocide 39 SAMEX Mining Corp. 39 Venous Thromboembolism 39 Reverse Circulation Drill 39 Neoplasms 39 Curipamba Project 39 FDA Panel Recommends 39 Taysan Copper Gold 39 Aortic Aneurysm 39 THAAD Battery 39 β catenin 39 Chinchan 39 ST Segment Elevation 39 Pending Merger 39 Liberia Poverty Reduction 39 upregulating 39 Strange Odor 39 LCQ# 39 Nullified 39 Nymox Reports 39 Debt Obligation 39 Desorption 39 Passport Requirement 39 Expands Scope 39 Market Disruption 39 Randomized Clinical Trials 39 Nuke Reactor 39 Farmout 39 Poorer Countries 39 Sitebrand Announces 39 Geophysical Surveys 39 Terminate Agreement 39 Empowerment Programme 39 Approves Revised 39 JNK1 39 Going Smoothly 39 Prostate Cancer Risk 39 Cockrell Ranch 39 Mop Up 39 anaphase promoting complex 39 thecompletion 39 Microbial Genome 39 Convertible Debenture Offering 39 Prostate Surgery 38 Wolf Haldenstein Investigates 38 Receipt 38 Explosive Materials 38 Worksite Enforcement 38 First BanCorp Announces 38 BHEM surveys 38 Imaging Technique 38 Bulk Tonnage 38 Surface Coating 38 Wilgerup 38 Destabilizing 38 Virologic Response 38 Retest 38 Urgent Needs 38 receptor kinase 38 Important Milestone 38 Rate Climbs 38 Consummates 38 Songa Dee 38 Byproduct 38 Sensitive Areas 38 Atwood Oceanics Announces 38 Ramco Gershenson Announces 38 Renewed Effort 38 Implant Sciences Announces 38 Escrow Release Conditions 38 Uige Province 38 Vulnerability Assessments 38 Peaceful Resolution 38 License Renewal 38 reactivations 38 BMP2 38 Repaired 38 gene rearrangements 38 intraventricular 38 Financing Transaction 38 Unitholders Approve 38 Dose Reduction 38 Musculo Skeletal Disorders 38 Shareholders Approve Plan 38 Histological 38 Hellyer Mill 38 Bilgena Read Terms 38 Receives Positive Results 38 Ag Cu 38 Substantial Issuer Bid 38 Poses Risk 38 Pediatric Exclusivity 38 Reconstitute 38 Non Compliant 38 Could Pave Way 38 Escalated 38 Brigham Exploration Announces 38 Evaluation Tool 38 Drilling Underway 38 Moraxella bovis 38 Near Surface 38 Proposal contemplates 38 Dramatically Reduces 38 Avcorp announces 38 Commerciality 38 Src kinase 38 Confusion Surrounds 38 Waiver Request 38 Toreador Announces 38 Announces Bought Deal 38 missense mutation 38 Clarification Regarding 38 Volcanogenic Massive 38 Million Non Brokered 38 Acne Drug 38 Facial Nerve 38 Patient Enrolment 38 Prevent Suicides 38 ^ sup ^ 38 Backlog Reduction 38 Profitability Improvement 38 Geokinetics Announces 38 UPDRS Part III 38 Permeation 38 ATL/TV# 38 Kalsaka Gold 38 metaphase 38 Diamondiferous 38 Equity Financings 38 ± SEM 38 DNA demethylation

Back to home page